An analysis contracted by WellDoc found that the company’s digital therapeutic for Type 2 diabetes management could lead to an average savings of more than $250 per patient per month. “The cost of a ...
Sight Sciences' analysis shows TearCare can save health plans $36.87 PMPY over traditional dry eye treatments in the U.S. Results from a Budget Impact Analysis indicate that a 20% increase in market ...
The introduction of lebrikizumab, a novel monoclonal antibody targeting interleukin-13 for severe atopic dermatitis (AD), was associated with cost savings of approximately €3.3 million over 3 years ...
OVERLAND PARK, Kan.--(BUSINESS WIRE)--Lucet, the behavioral health ecosystem for health plans, providers and members, today announced the results of the company’s 2024 Validation Report. Certified ...
Meta-analyzed RCTs showed home UVB was not inferior to clinic UVB for >50% repigmentation (OR 1.04) and >75% repigmentation (OR 1.26), albeit with wide CIs. Evidence base was limited to Fitzpatrick ...
Prognostic significance of ctDNA detection at the time of relapse during melanoma surveillance. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This abstract does not include a ...
Time Burdens for Participants With Advanced Cancer in Phase I Trials: A Cross-Sectional Study Globally, cancer drug expenditure exceeds $185 in US dollars (USD) billion, with the United States ...
In today’s uncertain economic climate, brands are seeking strategic opportunities to reduce costs and strengthen resilience. According to a 2025 study by Boston Consulting Group, cost management was ...
Wegovy (semaglutide) is a self-injectable prescription weight loss medicine that has helped people with obesity. It is to be used in conjunction with an appropriate dietary regimen and increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results